Ngôn ngữ / Language:
Đăng nhập Đăng ký Hội viên
Hoi Tim mach hoc Viet Nam
   
 
 
Tin tức
Tin Hoạt động
Liên kết qua Internet
Video
Tin tiếng Anh
MedScape Cardiology
TheHeart.org
InCirculation.Net
EuroPCR & AsiaPCR
TCTMd Conference
European Society of Cardiology
 
Trang chủ / Liên kết qua Internet  Print     Email
Liên kết qua Internet
Các Hội Tim mạch và Y khoa (6/23/2010)
Liên kết tới các Hội Tim mạch và Y khoa khác trên Internet ... Chi tiết
Tạp chí Tim mạch và Y học Trực tuyến (6/23/2010)
Liên kết tới các Tạp chí Tim mạch và Y học Trực tuyến qua Internet ... Chi tiết

MedScape Cardiology
Optimal Beta-blockers May Avert Post-ICD Shock HF Decompensation (Wed, 28 Jun 2017 13:57:49 EDT)
A spike in sympathetic activation after shocks, whether appropriate or not, may raise the risk of heart-failure decompensation within a few months, but maybe less so if beta-blockers were on board at that time.
Medscape Medical News
REVEAL: CETP Inhibitor Anacetrapib Meets Primary End Point (Tue, 27 Jun 2017 16:41:56 EDT)
Anacetrapib significantly reduced major coronary events compared with placebo in patients at risk for cardiac events already receiving a statin in the REVEAL phase 3 study, Merck announced today.
Medscape Medical News
Leadless Pacing Update: Nanostim Battery Fix, Micra Safety Upheld (Tue, 27 Jun 2017 13:47:12 EDT)
Leadless pacemakers are here, but questions remain. St Jude's Nanostim may soon be back on track, and now more is known about extracting one. Medtronic's Micra works and seems safe in the short term.
Medscape Medical News
Changes in Peripheral Blood Cells Linked to Increased CHD (Tue, 27 Jun 2017 10:09:33 EDT)
Genetic changes in peripheral blood cells previously linked to blood cancers are now associated with increased coronary heart disease in humans and accelerated atherosclerosis in mice.
Medscape Medical News
Real-World Data on Left Atrial Appendage Closure Does Not Reassure (Mon, 26 Jun 2017 09:47:20 EDT)
Registry data from EHRA EUROPACE-CARDISTIM 2017 raise concerns that device complications and the need for antithrombotic therapy may limit any potential benefit for left atrial appendage closure.
theheart.org on Medscape
TheHeart.org
Optimal Beta-blockers May Avert Post-ICD Shock HF Decompensation (Wed, 28 Jun 2017 13:57:49 EDT)
A spike in sympathetic activation after shocks, whether appropriate or not, may raise the risk of heart-failure decompensation within a few months, but maybe less so if beta-blockers were on board at...

For complete story visit theheart.org.
REVEAL: CETP Inhibitor Anacetrapib Meets Primary End Point (Tue, 27 Jun 2017 16:41:56 EDT)
Anacetrapib significantly reduced major coronary events compared with placebo in patients at risk for cardiac events already receiving a statin in the REVEAL phase 3 study, Merck announced today. ...

For complete story visit theheart.org.
Leadless Pacing Update: Nanostim Battery Fix, Micra Safety Upheld (Tue, 27 Jun 2017 13:47:12 EDT)
Leadless pacemakers are here, but questions remain. St Jude's Nanostim may soon be back on track, and now more is known about extracting one. Medtronic's Micra works and seems safe in the short term....

For complete story visit theheart.org.
Changes in Peripheral Blood Cells Linked to Increased CHD (Tue, 27 Jun 2017 10:09:33 EDT)
Genetic changes in peripheral blood cells previously linked to blood cancers are now associated with increased coronary heart disease in humans and accelerated atherosclerosis in mice. Medscape...

For complete story visit theheart.org.
Real-World Data on Left Atrial Appendage Closure Does Not Reassure (Mon, 26 Jun 2017 09:47:20 EDT)
Registry data from EHRA EUROPACE-CARDISTIM 2017 raise concerns that device complications and the need for antithrombotic therapy may limit any potential benefit for left atrial appendage closure. ...

For complete story visit theheart.org.